Questions are swirling around the use of semaglutide, commonly sold under the brand name Ozempic, for weight loss. CBC’s Christine Birak explores the risks and benefits of off-label uses of the drug, which is traditionally used to treat Type 2 diabetes.
#Weightloss #Ozempic #health
Watch The National live on YouTube Sunday-Friday at 9 p.m. ET
Subscribe to The National:
https://www.youtube.com/user/CBCTheNational?sub_confirmation=1
Connect with The National online:
Facebook | https://www.facebook.com/thenational
Twitter | https://twitter.com/CBCTheNational
Instagram | https://www.instagram.com/cbcthenational
More from CBC News | https://www.cbc.ca/news
The National is the flagship of CBC News, showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault and Ian Hanomansing, our team of trusted reporters help you make sense of the world, wherever you are. The National was named Canada’s Best National Newscast by the Canadian Screen Awards and RTDNA Canada.
This content was originally published here.
